JEREMY SCHREIBER: Open Payments
NPI 1508234147 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478,044 in 735 payments from 13 companies in 2025. Trend: 2023 $422,609 · 2024 $279,032 · 2025 $478,044
Speaker / faculty: $321,581Travel & lodging: $61,950Consulting: $48,488Honoraria: $31,051Food & beverage: $14,975
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 179 | $122,995 |
| Neurocrine BioSciences, Inc. | 150 | $100,159 |
| Alkermes, Inc. | 143 | $71,002 |
| E.R. Squibb & Sons, L.L.C. | 81 | $62,730 |
| Teva Pharmaceuticals USA, Inc. | 48 | $52,276 |
| Axsome Therapeutics, Inc. | 74 | $37,545 |
| Biogen, Inc. | 41 | $30,791 |
| Janssen Pharmaceuticals, Inc | 5 | $200 |
| Sage Therapeutics, LLC | 6 | $175 |
| Novo Nordisk Inc | 4 | $76 |
Products named: CAPLYTA, INGREZZA, COBENFY, ARISTADA, AUSTEDO XR, Auvelity, ZURZUVAE, LYBALVI.
Industry payments across WV — which companies pay providers there.
